Mancini W R
Department of Pharmacology, University of Michigan Medical School, Ann Arbor 48109.
Cancer Chemother Pharmacol. 1992;30(2):139-44. doi: 10.1007/BF00686406.
The cellular metabolism of 3'-amino-2',3'-dideoxycytidine (3'-NH2-dCyd), a cytotoxic agent previously reported to be a poor substrate for purified Cyd/dCyd deaminase (dCydD), was compared with that of cytosine arabinoside (ara-C) in cells that displayed dCydD activity (HeLa) and in cells that did not (L1210). Growth inhibition induced by 3'-NH2-dCyd was dependent on the levels of anabolic enzymes, particularly dCyd kinase (dCydK), whereas cytotoxicity induced by ara-C was dependent on the expression of both anabolic and catabolic enzyme activities. Competition kinetics using purified enzyme revealed that the binding affinity of ara-C to dCydK was 5-fold that of the amino analog. However, this binding advantage is apparently offset in cells that contain high levels of dCydD, since the Ki values for this enzyme were 0.2 and 23 mM for ara-C and 3'-NH2-dCyd, respectively. This was reflected in the decrease in analog sensitivity observed between the two cell lines, whereby the concentrations of ara-C and 3'-NH2-dCyd required to inhibit growth by 50% were 200 and 7 times higher, respectively, in the dCydD-containing HeLa cells as compared with the dCydD-deficient L1210 cells. The metabolic stability and cytotoxicity of 3'-NH2-dCyd was independent of cell number. An unexpected finding was the extent to which the effectiveness of ara-C could be mitigated by the number of dCydD-containing cells. A completely cytotoxic concentration of ara-C was rendered nontoxic by a 10-fold increase in cell number. This observation was supported by an increase in I-beta-D-arabinofuranosyluracil (ara-U) formation, a decrease in ara-C 5'-triphosphate (ara-CTP) accumulation, and a rise in cell viability with increasing cell number. These findings indicate that unlike ara-C, the effectiveness of 3'-NH2-dCyd is independent of the level of deaminase, which suggests its possible utility in situations in which high levels of deaminase are manifest.
3'-氨基-2',3'-二脱氧胞苷(3'-NH2-dCyd)是一种细胞毒性药物,此前有报道称它是纯化的胞苷/脱氧胞苷脱氨酶(dCydD)的不良底物。在具有dCydD活性的细胞(HeLa)和不具有该活性的细胞(L1210)中,将3'-NH2-dCyd的细胞代谢与阿糖胞苷(ara-C)的细胞代谢进行了比较。3'-NH2-dCyd诱导的生长抑制取决于合成代谢酶的水平,特别是dCyd激酶(dCydK),而ara-C诱导的细胞毒性则取决于合成代谢和分解代谢酶活性的表达。使用纯化酶的竞争动力学表明,ara-C与dCydK的结合亲和力是氨基类似物的5倍。然而,在含有高水平dCydD的细胞中,这种结合优势显然被抵消了,因为该酶对ara-C和3'-NH2-dCyd的Ki值分别为0.2和23 mM。这反映在两种细胞系之间观察到的类似物敏感性降低上,与缺乏dCydD的L1210细胞相比,在含有dCydD的HeLa细胞中,抑制生长50%所需的ara-C和3'-NH2-dCyd浓度分别高出200倍和7倍。3'-NH2-dCyd的代谢稳定性和细胞毒性与细胞数量无关。一个意外的发现是,含有dCydD的细胞数量对ara-C有效性的影响程度。细胞数量增加10倍会使完全具有细胞毒性浓度的ara-C变得无毒。这一观察结果得到了以下现象的支持:随着细胞数量增加,β-D-阿拉伯呋喃糖基尿嘧啶(ara-U)形成增加,阿糖胞苷5'-三磷酸(ara-CTP)积累减少,细胞活力上升。这些发现表明,与ara-C不同,3'-NH2-dCyd的有效性与脱氨酶水平无关,这表明它在脱氨酶水平较高的情况下可能具有实用价值。